Biodefense Application
Neurotoxicity Assessment
ResearchActive
Key Facts
About Renovaro BioSciences
Renovaro BioSciences, founded in 2013 and based in Los Angeles, is developing an AI-driven biology platform under the Lunai Bioworks banner to transform drug discovery. The company integrates genomic, proteomic, and phenotypic data with high-throughput in vivo modeling to uncover disease mechanisms and therapeutic candidates with higher precision. It is advancing internal programs in oncology and neurology while also pursuing strategic partnerships with pharmaceutical companies. Renovaro is a public company, positioning itself at the intersection of AI and biologics to address complex diseases.
View full company profile